Item 5.07. Submission of Matters to a Vote of Security Holders.
On March 3, 2021, AdaptHealth Corp. (the "Company") held a special meeting of
stockholders via live audio webcast (the "Special Meeting"). At the
Special Meeting, the Company's stockholders voted on the proposal described in
more detail below and in the Company's definitive proxy statement filed with the
Securities and Exchange Commission on January 20, 2020 (the "Proxy Statement").
At the beginning of the Special Meeting, there were 58,430,605 shares of Class A
Common Stock present or represented by proxy, which represented 66.14% of the
total shares of Class A Common Stock entitled to vote at the Special Meeting,
and which constituted a quorum for the transaction of business. Holders of the
Company's Class A Common Stock were entitled to one vote for each share of Class
A Common Stock held as of the close of business on January 4, 2021, the record
date for the Special Meeting.
The stockholders of the Company voted on the following proposal at the Special
Meeting:
1. To approve, for purposes of complying with Nasdaq Listing Rule 5635, the
issuance of shares of the Company's Class A Common Stock, par value $0.0001 per
share, representing equal to or greater than 20% of the outstanding common stock
or voting power of the Company issuable upon conversion of the Company's "Series
C Convertible Preferred Stock," par value $0.0001 per share ("Series C Preferred
Stock"), issued by the Company to the former equityholders of AeroCare Holdings,
Inc. ("AeroCare") pursuant to an Agreement and Plan of Merger entered into on
December 1, 2020, by and among the Company, AH Apollo Merger Sub Inc., a
Delaware corporation and a wholly-owned direct subsidiary of the Company, AH
Apollo Merger Sub II Inc., a Delaware corporation and wholly-owned direct
subsidiary of the Company, AeroCare Holdings, Inc., a Delaware corporation, and
Peloton Equity, LLC, a Delaware limited liability company, solely in its
capacity as the representative, agent and attorney-in-fact of the AeroCare
equityholders, by removal of the conversion restriction that prohibits such
conversion of Series C Preferred Stock (the "Proposal").
The voting results for the Proposal are set forth below.
For Against Abstain
58,408,854 14,642 7,109
Based on the votes set forth above, the stockholders approved the Proposal.
© Edgar Online, source Glimpses
ADAPTHEALTH CORP. 
